Frank Kramer

Drug Discovery, Clinical Sciences - Experimental Medicine, Bayer Pharma AG, Wuppertal, Germany, Germany


Frank Kramer, a holder of the Ph.D. degree, is a Director Biomarker Expert at the Global Biomarker Strategy and Development Department of Bayer Pharma AG in Wuppertal, Germany. Before Dr. Kramer investigated mechanisms of acute phase response regulation in the Cardiovascular Research Department at Sanofi-Aventis, he held appointments at Wyeth Pharmaceuticals in Germany and Ireland. Dr. Kramer authored publications and patents in the field of cardiovascular and cardiopulmonary in vitro, in vivo, and clinical research.

Biography Updated on 22 January 2013

Scholarly Contributions [Data Provided by ]